Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Heart Failure, and Bone Marrow Aspiration.

David Polhemus is a primary care provider, practicing in Cardiologist in Baltimore, Maryland. Dr. Polhemus is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Failure, Metabolic Syndrome, Heart Failure with Preserved Ejection Fraction (HFpEF), and Heart Attack.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.

Dr. Aronis is an Assistant Professor of Medicine in the Division of Cardiology at the Johns Hopkins School of Medicine, the Director of the Complex Adult Congenital Heart Disease Ablation Program, and the Associate Director of the Ventricular Tachycardia Ablation Program. He performs all types of electrophysiology procedures, with a special focus on complex catheter ablations for atrial and ventricular arrhythmias as well as complex ablations for arrhythmias in patients with adult congenital heart diseases. Dr. Aronis received his M.D. and Ph.D. degrees with Summa Cum Laude honors from the University of Patras School of Medicine in Greece. He completed his internal medicine residency training at Boston University Medical Center both his Cardiovascular Disease and Clinical Cardiac Electrophysiology fellowships at The Johns Hopkins Hospital. In addition, he has completed a post-doctoral research fellowship in Translational Research at Beth Israel Deaconess Medical Center / Harvard Medical School and an NIH funded (T-32) post-doctoral research fellowship in computational electrophysiology at the Institute of Computational Medicine at the Johns Hopkins Whiting School of Engineering. He actively engages in clinical trials and research studies aimed at improving patient outcomes and advancing the understanding of cardiac arrhythmias. He is a member of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Aronis is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Andrew Feinberg studied mathematics and humanities at Yale in the Directed Studies honors program, and he received his B.A. (1973) and M.D. (1976) from the accelerated medical program at Johns Hopkins University, as well as an M.P.H. from Johns Hopkins (1981). He performed a postdoctoral fellowship in developmental biology at UCSD, clinical training in medicine at University of Pennsylvania, and genetics research and clinical training at Johns Hopkins. Dr. Feinberg is considered the founder of the field of cancer epigenetics, having discovered altered DNA methylation in cancer in the early 1980’s with Bert Vogelstein. Over the decades since, Feinberg and his colleagues have shaped the landscape of our understanding of DNA methylation and other epigenetic changes, and their applications to epidemiology and medicine, and have introduced groundbreaking statistical and laboratory methods to the study of the epigenome. He and his colleagues discovered human imprinted genes and loss of imprinting (LOI) in cancer, and they proved the epigenetic hypothesis of cancer through their work on Beckwith-Wiedemann syndrome. Most recently, they pioneered genome-scale epigenetics (epigenomics), with the first NIH funded Epigenome Center, pioneering methods including the first comprehensive genome-scale methylation discovering the major target for epigenetic variation in humans, CpG island shores. He led the first whole genome bisulfite sequencing analysis of human cancer, discovering large hypomethylated blocks that correspond to nuclear lamina-associated heterochromatin, as well as a mechanism for disruption of these blocks in epithelial-mesenchymal transition. He has also helped to create the field of epigenetic epidemiology, discovering epigenetic mediation of genetic variants in disease. He has made several important theoretical contributions as well, including the epigenetic progenitor hypothesis of cancer and the role of entropy in epigenetic development and disease. He is a Bloomberg Distinguished Professor in the Johns Hopkins University Schools of Medicine, Engineering and Public Health, where he is Director of the Center for Epigenetics. He is a recipient of an NIH Director’s Pioneer Award, is a member of the National Institute of Medicine, the American Academy of Arts and Science, the NIH Council of Councils, and he has received honorary doctorates from the University of Uppsala, the Karolinska Institute, and the University of Amsterdam. Feinberg Lab Website. Dr. Feinberg is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Autism Spectrum Disorder, Acute Myeloid Leukemia (AML), Leukemia, and Metabolic Syndrome.

Luigi Ferrucci is a primary care provider, practicing in General Practice in Baltimore, Maryland. Dr. Ferrucci is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Peripheral Artery Disease, Dementia, Atherosclerosis, Alzheimer's Disease, and Hormone Replacement Therapy (HRT).

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Harry A. Silber is an associate professor of medicine at the Johns Hopkins University School of Medicine. His clinical work specializes in cardiac disease and his research focuses on vascular function by MRI and non-invasive assessment of cardiac filling pressure. Dr. Silber received a doctorate in biomedical engineering as well as a medical degree from Tulane University. He completed a residency at the Hospital of the University of Pennsylvania before being selected for a fellowship in cardiology at Johns Hopkins Hospital. He joined the Johns Hopkins faculty in 2000. Dr. Silber has published extensively and holds several patents for his research for cardiovascular disease. Dr. Silber is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Apoplexy, Heart Attack, Heart Failure, and Arterial Embolism.

Dr. Marlene Stephanie Williams is an Associate professor at the Johns Hopkins University School of Medicine. Her research focuses on coronary atherosclerosis and platelet function, and her particular focus is on platelet function as it relates to the acute coronary syndrome. Dr. Williams has examined platelet function and its correlation to platelet functional genomics and runs a platelet physiology laboratory on the Johns Hopkins Bayview campus. The goal for her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may improve this dysfunction that may eventually be translated to therapies for patients with cardiovascular disease. She is a prior recipient of an NIH career mentored award (K23) examining platelet functional genomics and an NIH RO1 award addressing platelet serotonin signaling in depression and heart disease. Dr. Williams has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, and heart disease and depression. She has participated in several NHLBI advisory committees, review groups, and study sections. Dr. Williams has been the Course Director, of the advanced clinical clerkship in coronary intensive care at the Bayview Medical center and has mentored many medical residents and cardiology fellows. Dr. Williams received her undergraduate degree in biochemistry from McGill University. She earned a medical degree from the Columbia University College of Physicians & Surgeons and completed a residency at Johns Hopkins Hospital. After completing a residency, Dr. Williams was a cardiology fellow at Mount Sinai Hospital and Johns Hopkins Hospital. Dr. Williams is currently the Clinical Director of Cardiology at Johns Hopkins Bayview Medical Center. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Pacemaker Implantation, and Hormone Replacement Therapy (HRT).

Dr. Shapiro is a professor of Medicine at Johns Hopkins University and director of the non-invasive cardiology labs at Johns Hopkins Bayview Medical Center. He trained at Johns Hopkins School of Medicine in internal medicine and at the University of Chicago in Cardiology. He has long term interests in cardiac imaging, left ventricular deformation, left ventricular diastolic function, and non-invasive imaging, and has published more than 100 papers on these subjects. His original work utilized echocardiography, then cardiac MRI, and now cardiac CT. Currently, in addition to seeing and following patients with a wide variety of cardiac diseases, he is devoting much of his time toward teaching and research in cardiac CT angiography. Dr. Shapiro directs the Johns Hopkins Cardiac CT Practicum, a course that trains cardiologists and radiologists to interpret Cardiac CT, that has become popular and well known the world over. Dr. Shapiro is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Apoplexy, Coronary Heart Disease, and Angina.

Pamela Ouyang is a Cardiologist in Baltimore,, Maryland. Dr. Ouyang is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Atherosclerosis, Menopause, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, and Hormone Replacement Therapy (HRT).

Dr. Monica Mukherjee is an adult cardiologist and an Associate Professor of Medicine at the Johns Hopkins University Division of Cardiology and specializes in advanced cardiac imaging. She serves as Medical Director of the Echocardiography Lab at Johns Hopkins Bayview Medical Center, and as Associate Director of the Johns Hopkins Echocardiography program across the institution. Dr. Mukherjee graduated Summa Cum Laude with dual Bachelors of Science in Psychology and Behavioral Neurosciences from the University of Florida. She received her Doctorate in Medicine from the George Washington University in Washington, DC, and internal medicine residency at Drexel University, before returning to George Washington to complete her fellowship in cardiovascular disease. She has a MPH from the Johns Hopkins Bloomberg School of Public Health with a special concentration in Epidemiological and Biostatistical Methods for Public Health and Clinical Research. Dr. Mukherjee has an accomplished academic career with multiple research awards focused on right ventricular remodeling in heart failure, pulmonary hypertension, and scleroderma. She was the recipient of the 2020 Johns Hopkins University Clinician Scientist Award and also has been funded by the National Institutes of Health, the Scleroderma Foundation, and the CHEST Foundation. She was awarded the Top 25 Young Investigators Award from the American Society of Echocardiography in 2016. Dr. Mukherjee is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Pulmonary Hypertension, Heart Attack, Systemic Sclerosis (SSc), Tissue Biopsy, and Pacemaker Implantation.